Stefańska B, Dzieduszycka M, Bontemps-Gracz M, Borowski E, Martelli S
Department of Pharmaceutical Technology and Biochemistry, Technical University of Gdańsk, Poland.
J Antibiot (Tokyo). 1988 Feb;41(2):193-8. doi: 10.7164/antibiotics.41.193.
Eleven N-enamine derivatives of daunorubicin and of its 5-imino analogue as well as of doxorubicin have been synthesized and evaluated for antileukemic activity in vitro and in vivo. Comparison of biological activities of examined compounds with other enamine derivatives of daunorubicin, reported earlier by us, has indicated that the optimal activity is shown by N-(1-carboethoxypropen-1-yl-2)daunorubicin.
已合成了柔红霉素及其5-亚氨基类似物以及阿霉素的11种N-烯胺衍生物,并对其体外和体内抗白血病活性进行了评估。将所研究化合物的生物活性与我们之前报道的柔红霉素其他烯胺衍生物进行比较,结果表明N-(1-乙氧羰基丙烯-1-基-2)柔红霉素表现出最佳活性。